Novo Nordisk's Wegovy wins India nod for fatty liver disease; Emcure to distribute

Novo Nordisk’s Wegovy wins India nod for fatty liver disease; Emcure to distribute

Novo Nordisk has secured regulatory approval for Wegovy as the first and only GLP-1 receptor agonist for the treatment of adults with metabolic dysfunction-associated steatohepatitis (MASH) in India, expanding the blockbuster obesity drug’s approved use beyond chronic weight management. The approval was granted by the Central Drugs Standard Control Organisation (CDSCO) for the 2.4 mg…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

HDFC Bank, ICICI Bank, Axis Bank, Kotak Mahindra Bank Q1 results preview – 5 things investors should watch for on July 18 – Markets

Banking Sector Q1 Preview: Major private lenders HDFC Bank, ICICI Bank, Axis Bank and Kotak Mahindra Bank will announce Q1 results on July 19. (Image: ET Now) The banking sector will be in sharp focus on July 19, with major private lenders including HDFC Bank, ICICI Bank, Kotak Mahindra Bank, and Axis Bank scheduled to…

Read More
Federal Bank Q1 Results: Strong core income, lower provisions aid profit; Asset quality stable

Federal Bank Q1 Results: Strong core income, lower provisions aid profit; Asset quality stable

Federal Bank Ltd., the Kochi-based private sector lender, reported its results for the quarterly period that concluded on June 30 on Friday, July 17. The results were better on a year-on-year basis on the profitability and the interest income front. The lender reported its Net Interest Income (NII) of ₹2,946 crore during the June quarter,…

Read More
Alpine Texworld IPO allotment today: Check status online, latest GMP, listing date and more - Markets

Alpine Texworld IPO allotment today: Check status online, latest GMP, listing date and more – Markets

“As a journalist, the details always tell the story” – this quote by American author and musician James McBride describes a scribe in a nut shell. Meet Shubhobrota Devroy, who carries this journalism sentiment in his heart. As an experienced business journalist, he is always on a steep learning curve in his profession. From macroeconomics,…

Read More
Explained - Why brokerages are split on Tech Mahindra despite its Q1 earnings beat

Explained – Why brokerages are split on Tech Mahindra despite its Q1 earnings beat

Shares of Tech Mahindra Ltd. rose as much as 3.5% on Friday, July 17, after the IT services company’s June-quarter earnings beat street expectations on revenue, margins and constant currency growth. Despite the strong operational performance, brokerages remain divided on the stock, with target prices ranging from ₹1,260 to ₹1,635. The stock was trading 1.85%…

Read More